Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PCRX | US
-0.60
-2.77%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
05/07/2024
21.06
21.59
21.59
20.82
Pacira BioSciences Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL a bupivacaine liposome injectable suspension; ZILRETTA a triamcinolone acetonide extended-release injectable suspension; and iovera system a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals Inc. and changed its name to Pacira BioSciences Inc. in April 2019. Pacira BioSciences Inc. was incorporated in 2006 and is headquartered in Tampa Florida.
View LessValue Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
105.2%1 month
74.9%3 months
56.7%6 months
47.8%18.95
9.77
1.43
0.65
0.37
10.07
2.31
-3.83
167.82M
980.26M
980.26M
-
9.05
29.10
4.20
8.49
10.08
19.83
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
9.09
Range1M
10.61
Range3M
11.15
Rel. volume
0.94
Price X volume
25.08M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 32.18 | 1.05B | -0.56% | 12.83 | 283.56% |
Ironwood Pharmaceuticals Inc | IRWD | Drug Manufacturers-Specialty & Generic | 6.49 | 1.03B | 6.22% | n/a | -208.89% |
OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.26 | 878.21M | 3.70% | n/a | 33.49% |
Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 22.12 | 782.65M | 2.38% | n/a | 318.94% |
Evolus Inc | EOLS | Drug Manufacturers-Specialty & Generic | 10.93 | 684.33M | -0.55% | n/a | 686.72% |
Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 16.85 | 682.49M | -1.69% | 50.82 | 193.63% |
PetIQ Inc | PETQ | Drug Manufacturers-Specialty & Generic | 22.71 | 675.66M | 0.49% | 95.91 | 196.89% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 6.34 | 649.85M | -2.31% | n/a | 136.53% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 2.87 | 432.37M | 3.61% | n/a | -530.63% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 15.15 | 423.93M | -4.60% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Interface Inc | TILE | Textile Manufacturing | 14.49 | 843.94M | -2.56% | 14.53 | 113.37% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 17.73 | 799.13M | -2.42% | n/a | 4070.84% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 32.65 | 667.35M | -2.74% | n/a | 4.21% |
Ennis Inc | EBF | Building Products & Equipment | 21.25 | 552.16M | -0.75% | 13.68 | 1.15% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 4.48 | 428.47M | -2.40% | n/a | 138.85% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 25.77 | 412.92M | -1.68% | n/a | 322.60% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.74 | 369.15M | -2.49% | 14.12 | 86.68% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.36 | 324.63M | -2.40% | 10.10 | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 2.74 | 316.67M | -3.52% | 75.75 | 80.81% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.55 | 298.02M | -0.34% | 8.24 | 25.57% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 10.07 | 5.00 | Expensive |
Ent. to Revenue | 2.31 | 136.32 | Cheaper |
PE Ratio | 18.95 | 28.33 | Cheaper |
Price to Book | 1.43 | 9.90 | Cheaper |
Dividend Yield | - | 4.13 | - |
Std. Deviation (3M) | 56.71 | 70.65 | Par |
Debt to Equity | 0.65 | -2.08 | Expensive |
Debt to Assets | 0.37 | 0.46 | Cheaper |
Market Cap | 980.26M | 4.40B | Emerging |